See also this year's filing and all EDGAR filings for this company.
PDF Report 0001316175_2013_Anthera_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001316175, Anthera Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 25,179,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,150,000 |
| 3 | remainder_Assets | 116,000 |
| 4 | LiabilitiesCurrent | 18,750,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 11,221,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,715,000 |
| 9 | ResearchAndDevelopmentExpense | 49,219,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -3,465,000 |
| 13 | remainder_ComprehensiveNetIncome | 12,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 26,445,000 |
| 1 | Liabilities | 29,971,000 |
| 2 | Expenses | 55,934,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -3,526,000 |
| 5 | NetIncome | -59,399,000 |
| 6 | ComprehensiveNetIncome | -59,393,000 |
| 7 | BaseVar | 57,913,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.38 |
| 9 | EconomicCapitalRatio | 0.897 |